Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.07
HRC's Cash to Debt is ranked lower than
96% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. HRC: 0.07 )
Ranked among companies with meaningful Cash to Debt only.
HRC' s Cash to Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.62 Max: 2.32
Current: 0.07
0.07
2.32
Equity to Asset 0.28
HRC's Equity to Asset is ranked lower than
88% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. HRC: 0.28 )
Ranked among companies with meaningful Equity to Asset only.
HRC' s Equity to Asset Range Over the Past 10 Years
Min: 0.17  Med: 0.44 Max: 0.67
Current: 0.28
0.17
0.67
Interest Coverage 1.81
HRC's Interest Coverage is ranked lower than
94% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.76 vs. HRC: 1.81 )
Ranked among companies with meaningful Interest Coverage only.
HRC' s Interest Coverage Range Over the Past 10 Years
Min: 4.52  Med: 14.91 Max: 25.97
Current: 1.81
4.52
25.97
F-Score: 6
Z-Score: 1.88
M-Score: -2.24
WACC vs ROIC
7.14%
3.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.44
HRC's Operating margin (%) is ranked lower than
51% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. HRC: 4.44 )
Ranked among companies with meaningful Operating margin (%) only.
HRC' s Operating margin (%) Range Over the Past 10 Years
Min: -27.59  Med: 9.68 Max: 16.18
Current: 4.44
-27.59
16.18
Net-margin (%) 1.56
HRC's Net-margin (%) is ranked lower than
54% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. HRC: 1.56 )
Ranked among companies with meaningful Net-margin (%) only.
HRC' s Net-margin (%) Range Over the Past 10 Years
Min: -29.2  Med: 7.54 Max: 11.27
Current: 1.56
-29.2
11.27
ROE (%) 3.71
HRC's ROE (%) is ranked lower than
53% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. HRC: 3.71 )
Ranked among companies with meaningful ROE (%) only.
HRC' s ROE (%) Range Over the Past 10 Years
Min: -47.88  Med: 14.06 Max: 21.05
Current: 3.71
-47.88
21.05
ROA (%) 1.11
HRC's ROA (%) is ranked lower than
53% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. HRC: 1.11 )
Ranked among companies with meaningful ROA (%) only.
HRC' s ROA (%) Range Over the Past 10 Years
Min: -27.72  Med: 7.40 Max: 10.58
Current: 1.11
-27.72
10.58
ROC (Joel Greenblatt) (%) 13.99
HRC's ROC (Joel Greenblatt) (%) is ranked higher than
56% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. HRC: 13.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HRC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -66.76  Med: 28.66 Max: 61.42
Current: 13.99
-66.76
61.42
Revenue Growth (3Y)(%) 9.00
HRC's Revenue Growth (3Y)(%) is ranked higher than
71% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.10 vs. HRC: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HRC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.4  Med: 3.80 Max: 9
Current: 9
-11.4
9
EBITDA Growth (3Y)(%) -8.60
HRC's EBITDA Growth (3Y)(%) is ranked lower than
79% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. HRC: -8.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HRC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -63.9  Med: -0.50 Max: 138.3
Current: -8.6
-63.9
138.3
EPS Growth (3Y)(%) -25.10
HRC's EPS Growth (3Y)(%) is ranked lower than
81% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. HRC: -25.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HRC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -25.1  Med: 0.80 Max: 28.9
Current: -25.1
-25.1
28.9
» HRC's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-07)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

HRC Guru Trades in Q2 2015

Pioneer Investments 77,453 sh (New)
Ken Fisher 1,647,237 sh (-0.05%)
Chuck Royce 504,270 sh (-3.28%)
Jim Simons 385,200 sh (-3.77%)
David Dreman 170,143 sh (-18.24%)
Paul Tudor Jones 178,500 sh (-47.02%)
Steven Cohen 122,753 sh (-73.15%)
» More
Q3 2015

HRC Guru Trades in Q3 2015

Ray Dalio 8,078 sh (New)
Pioneer Investments 102,958 sh (+32.93%)
Jim Simons 507,300 sh (+31.70%)
David Dreman 191,069 sh (+12.30%)
Chuck Royce 504,270 sh (unchged)
Steven Cohen Sold Out
Ken Fisher 1,595,040 sh (-3.17%)
Paul Tudor Jones 14,000 sh (-92.16%)
» More
Q4 2015

HRC Guru Trades in Q4 2015

Steven Cohen 493,900 sh (New)
Jim Simons 821,500 sh (+61.94%)
Paul Tudor Jones 21,123 sh (+50.88%)
Pioneer Investments 118,006 sh (+14.62%)
Ray Dalio Sold Out
David Dreman Sold Out
Ken Fisher 1,588,444 sh (-0.41%)
Chuck Royce 409,576 sh (-18.78%)
» More
Q1 2016

HRC Guru Trades in Q1 2016

Joel Greenblatt 39,704 sh (New)
David Dreman 187,195 sh (New)
Paul Tudor Jones 361,800 sh (+1612.82%)
Steven Cohen 921,600 sh (+86.60%)
Pioneer Investments 124,849 sh (+5.80%)
Chuck Royce 409,576 sh (unchged)
Ken Fisher 1,570,560 sh (-1.13%)
Jim Simons 734,700 sh (-10.57%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NYSE:CMN, OSTO:LIFCO B, XTER:GXI, MIL:AMP, ASX:ANN » details
Traded in other countries:HB9.Germany,
Hill-Rom Holdings Inc is engaged in selling and renting patient support and near-patient technologies and services, and health information technology solutions in the U.S. and Canada.

Hill-Rom Holdings Inc was incorporated on August 7, 1969 in the State of Indiana. The Company is a manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. Health care providers use the Company's comprehensive product and service offerings across the health care continuum in hospitals, extended care facilities and home care settings, to enhance the safety and quality of patient care. The Company operates in three segments namely North America, Surgical and Respiratory Care and International. The North America segment sells and rents its patient support and near-patient technologies and services, as well as health information technology solutions in the U.S. and Canada. The Surgical and Respiratory Care segment sells and rents surgical and respiratory care products. The International segment sells and rents its products outside of the U.S. and Canada. The Company sells and rent its product to acute and extended care health care facilities through both direct sales force and distributors. It also sell products to patients in the home. It competes on the basis of clinical expertise such as as Joerns Healthcare , Freedom Medical, Inc., Covidien, Ltd., Action Medical, Electromed, Inc.

Ratios

vs
industry
vs
history
P/E(ttm) 85.97
HRC's P/E(ttm) is ranked lower than
86% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.16 vs. HRC: 85.97 )
Ranked among companies with meaningful P/E(ttm) only.
HRC' s P/E(ttm) Range Over the Past 10 Years
Min: 7.13  Med: 17.94 Max: 95.16
Current: 85.97
7.13
95.16
Forward P/E 12.84
HRC's Forward P/E is ranked higher than
95% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.96 vs. HRC: 12.84 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 84.50
HRC's PE(NRI) is ranked lower than
85% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.68 vs. HRC: 84.50 )
Ranked among companies with meaningful PE(NRI) only.
HRC' s PE(NRI) Range Over the Past 10 Years
Min: 8.93  Med: 19.86 Max: 92.86
Current: 84.5
8.93
92.86
Price/Owner Earnings (ttm) 23.86
HRC's Price/Owner Earnings (ttm) is ranked higher than
60% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.85 vs. HRC: 23.86 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HRC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.43  Med: 14.75 Max: 228.03
Current: 23.86
6.43
228.03
P/B 2.75
HRC's P/B is ranked lower than
51% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. HRC: 2.75 )
Ranked among companies with meaningful P/B only.
HRC' s P/B Range Over the Past 10 Years
Min: 0.58  Med: 2.42 Max: 4.23
Current: 2.75
0.58
4.23
P/S 1.30
HRC's P/S is ranked higher than
70% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. HRC: 1.30 )
Ranked among companies with meaningful P/S only.
HRC' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 1.27 Max: 1.95
Current: 1.3
0.4
1.95
PFCF 23.49
HRC's PFCF is ranked higher than
65% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.49 vs. HRC: 23.49 )
Ranked among companies with meaningful PFCF only.
HRC' s PFCF Range Over the Past 10 Years
Min: 8.49  Med: 13.45 Max: 255.09
Current: 23.49
8.49
255.09
POCF 14.00
HRC's POCF is ranked higher than
57% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.58 vs. HRC: 14.00 )
Ranked among companies with meaningful POCF only.
HRC' s POCF Range Over the Past 10 Years
Min: 3.32  Med: 9.09 Max: 68.63
Current: 14
3.32
68.63
EV-to-EBIT 50.90
HRC's EV-to-EBIT is ranked lower than
85% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.36 vs. HRC: 50.90 )
Ranked among companies with meaningful EV-to-EBIT only.
HRC' s EV-to-EBIT Range Over the Past 10 Years
Min: -29.7  Med: 12.50 Max: 64.8
Current: 50.9
-29.7
64.8
EV-to-EBITDA 19.51
HRC's EV-to-EBITDA is ranked lower than
63% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.91 vs. HRC: 19.51 )
Ranked among companies with meaningful EV-to-EBITDA only.
HRC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.5  Med: 8.30 Max: 114
Current: 19.51
-6.5
114
Shiller P/E 44.16
HRC's Shiller P/E is ranked lower than
56% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.39 vs. HRC: 44.16 )
Ranked among companies with meaningful Shiller P/E only.
HRC' s Shiller P/E Range Over the Past 10 Years
Min: 4.04  Med: 21.33 Max: 67.42
Current: 44.16
4.04
67.42
Current Ratio 2.00
HRC's Current Ratio is ranked lower than
63% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. HRC: 2.00 )
Ranked among companies with meaningful Current Ratio only.
HRC' s Current Ratio Range Over the Past 10 Years
Min: 1.33  Med: 2.29 Max: 3.1
Current: 2
1.33
3.1
Quick Ratio 1.48
HRC's Quick Ratio is ranked lower than
57% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. HRC: 1.48 )
Ranked among companies with meaningful Quick Ratio only.
HRC' s Quick Ratio Range Over the Past 10 Years
Min: 1.15  Med: 1.96 Max: 2.72
Current: 1.48
1.15
2.72
Days Inventory 63.33
HRC's Days Inventory is ranked higher than
86% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.83 vs. HRC: 63.33 )
Ranked among companies with meaningful Days Inventory only.
HRC' s Days Inventory Range Over the Past 10 Years
Min: 41.63  Med: 46.99 Max: 73.07
Current: 63.33
41.63
73.07
Days Sales Outstanding 72.84
HRC's Days Sales Outstanding is ranked lower than
63% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.25 vs. HRC: 72.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
HRC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.95  Med: 88.82 Max: 95.65
Current: 72.84
76.95
95.65
Days Payable 33.88
HRC's Days Payable is ranked lower than
75% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.30 vs. HRC: 33.88 )
Ranked among companies with meaningful Days Payable only.
HRC' s Days Payable Range Over the Past 10 Years
Min: 29.19  Med: 36.28 Max: 45.39
Current: 33.88
29.19
45.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.33
HRC's Dividend Yield is ranked higher than
50% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. HRC: 1.33 )
Ranked among companies with meaningful Dividend Yield only.
HRC' s Dividend Yield Range Over the Past 10 Years
Min: 0.89  Med: 1.53 Max: 6.05
Current: 1.33
0.89
6.05
Dividend Payout 1.11
HRC's Dividend Payout is ranked lower than
86% of the 96 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.37 vs. HRC: 1.11 )
Ranked among companies with meaningful Dividend Payout only.
HRC' s Dividend Payout Range Over the Past 10 Years
Min: 0.11  Med: 0.33 Max: 5.65
Current: 1.11
0.11
5.65
Dividend Growth (3y) 9.10
HRC's Dividend Growth (3y) is ranked lower than
64% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.90 vs. HRC: 9.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
HRC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -28.8  Med: 6.30 Max: 11.4
Current: 9.1
-28.8
11.4
Forward Dividend Yield 1.39
HRC's Forward Dividend Yield is ranked lower than
51% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.46 vs. HRC: 1.39 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.10
HRC's Yield on cost (5-Year) is ranked higher than
58% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. HRC: 2.10 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HRC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.41  Med: 2.42 Max: 9.57
Current: 2.1
1.41
9.57
3-Year Average Share Buyback Ratio -2.30
HRC's 3-Year Average Share Buyback Ratio is ranked higher than
56% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.90 vs. HRC: -2.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HRC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.3  Med: 0.60 Max: 3.1
Current: -2.3
-2.3
3.1

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.39
HRC's Price/Projected FCF is ranked higher than
70% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. HRC: 1.39 )
Ranked among companies with meaningful Price/Projected FCF only.
HRC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.37  Med: 0.95 Max: 9.08
Current: 1.39
0.37
9.08
Price/Median PS Value 1.03
HRC's Price/Median PS Value is ranked higher than
55% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. HRC: 1.03 )
Ranked among companies with meaningful Price/Median PS Value only.
HRC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.33  Med: 0.85 Max: 1.49
Current: 1.03
0.33
1.49
Earnings Yield (Greenblatt) (%) 1.98
HRC's Earnings Yield (Greenblatt) (%) is ranked lower than
52% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. HRC: 1.98 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HRC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.5  Med: 6.90 Max: 16.3
Current: 1.98
1.5
16.3
Forward Rate of Return (Yacktman) (%) 2.13
HRC's Forward Rate of Return (Yacktman) (%) is ranked lower than
70% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.42 vs. HRC: 2.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HRC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -21.2  Med: 3.10 Max: 20.6
Current: 2.13
-21.2
20.6

More Statistics

Revenue (TTM) (Mil) $2,342
EPS (TTM) $ 0.57
Beta1.07
Short Percentage of Float1.56%
52-Week Range $42.99 - 58.73
Shares Outstanding (Mil)65.38

Analyst Estimate

Sep16 Sep17
Revenue (Mil $)
EPS ($) 3.30 3.81
EPS without NRI ($) 3.30 3.81
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for HRC

Headlines

Articles On GuruFocus.com
Hill-Rom Q2 Earnings Beat Market Estimates May 09 2015 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 
Weekly CEO Buys Highlight: AOL Inc, Consolidated Graphics Inc, Saul Centers Inc, Hill-ROM Holdings, May 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) CEO John J Greisch buys 30,000 Shares May 12 2010 
HILL-ROM HOLDINGS, INC. Reports Operating Results (10-Q) Feb 04 2010 

More From Other Websites
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference May 24 2016
Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference May 24 2016
Haldor Advanced Technologies Ltd. and Hill-Rom Enter into Exclusive Global Distribution Partnership... May 12 2016
Hill-Rom to Participate in the UBS Global Healthcare Conference May 10 2016
Hill-Rom to Participate in the UBS Global Healthcare Conference May 10 2016
HILL-ROM HOLDINGS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Submission... May 09 2016
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference May 06 2016
Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference May 06 2016
Hill-Rom Declares Third Quarter 2016 Dividend May 06 2016
Hill-Rom Declares Third Quarter 2016 Dividend May 06 2016
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2016
HILL-ROM HOLDINGS, INC. Financials May 05 2016
Hill-Rom Holdings, Inc. :HRC-US: Earnings Analysis: Q2, 2016 By the Numbers May 05 2016
Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates May 04 2016
ETF’s with exposure to Hill-Rom Holdings, Inc. : May 3, 2016 May 03 2016
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference May 03 2016
Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference May 03 2016
Hill-Rom Holdings, Inc. breached its 50 day moving average in a Bearish Manner : HRC-US : May 2,... May 02 2016
Will This ‘Infectious’ Medical Device Maker Pass Its Latest Test? Apr 29 2016
Hill-Rom (HRC) Stock Dives on Q2 Revenue Miss, Outlook Apr 29 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)